People exposed to proton-pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched cohort study.

Kodvanj, Ivan; Homolak, Jan; Trkulja, Vladimir

Kodvanj, Ivan; Homolak, Jan; Trkulja, Vladimir.

Afiliação

Kodvanj I; Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb, Croatia.
Homolak J; Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia.
Trkulja V; Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia.

Br J Clin Pharmacol ; 89(2): 787-831, 2023 02.

Article em En | MEDLINE | ID: mdl-36094656

Assuntos

COVID-19; Inibidores da Bomba de Prótons; Adulto; Humanos; Inibidores da Bomba de Prótons/efeitos adversos; Estudos de Coortes; Teste para COVID-19; Hospitalização

Palavras-chave

COVID-19 disease; hospitalization; mortality; proton-pump inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Bomba de Prótons / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google